Skip to main content Accessibility help
×
Home
Hostname: page-component-56f9d74cfd-nww4m Total loading time: 0.602 Render date: 2022-06-27T12:29:35.012Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }

Article contents

Controlling sleeping sickness – a review

Published online by Cambridge University Press:  20 August 2009

S. C. WELBURN*
Affiliation:
Centre for Infectious Diseases, College of Medicine and Veterinary Medicine, The University of Edinburgh, Summerhall, Edinburgh, EH9 1QH
I. MAUDLIN
Affiliation:
Centre for Infectious Diseases, College of Medicine and Veterinary Medicine, The University of Edinburgh, Summerhall, Edinburgh, EH9 1QH
P. P. SIMARRO
Affiliation:
World Health Organization, Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, Geneva, Switzerland
*
Corresponding author: S. C. Welburn, Centre for Infectious Diseases, College of Medicine and Veterinary Medicine, The University of Edinburgh, Summerhall, Edinburgh, EH9 1QH. Tel: +44 131 650 6228. Fax: 44 (131) 650 7348. E-mail: sue.welburn@ed.ac.uk

Summary

Following a period characterized by severe epidemics of sleeping sickness, restoration of effective control and surveillance systems has raised the question of eliminating the disease from sub-Saharan Africa. Given sufficient political and financial support, elimination is now considered a reasonable aim in countries reporting zero or less than 100 cases per year. This success may lead health authorities across the affected region to downgrade the disease from ‘neglected’ to simply being ignored. In view of the significant levels of under-reporting of sleeping sickness mortality in rural communities, this could be a short-sighted policy. Loss of capacity to deal with new epidemics, which can arise as a consequence of loss of commitment or civil upheaval, would have serious consequences. The present period should be seen as a clear opportunity for public-private partnerships to develop simpler and more cost-effective tools and strategies for sustainable sleeping sickness control and surveillance, including diagnostics, treatment and vector control.

Type
Research Article
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Agranoff, D., Stich, A., Abel, P. and Krishna, S. (2005). Proteomic fingerprinting for the diagnosis of human African trypanosomiasis. Trends in Parasitology 21, 154157.CrossRefGoogle Scholar
Allsopp, R. and Hursey, B. S. (2004). The economics of African trypanosomiasis. In The Trypanosomiases, (ed. Maudlin, I., Holmes, P. H. and Miles, M. A.), pp. 491507. Wallingford, UK: CABI International.CrossRefGoogle Scholar
Ashcroft, M. T. (1959). The Tinde experiment. A further study of the long-term cyclical transmission of Trypanosoma rhodesiense. Annals of Tropical Medicine and Parasitology 53, 137146.CrossRefGoogle ScholarPubMed
Berrang Ford, L. (2007). Civil conflict and sleeping sickness in Africa in general and Uganda in particular. Conflict and Health 1, 6.CrossRefGoogle ScholarPubMed
Barrett, M. P., Boykin, D. W., Brun, R. and Tidwell, R. R. (2007). Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. British Journal of Pharmacology 152, 11551171.CrossRefGoogle ScholarPubMed
Brightwell, B., Dransfield, B., Maudlin, I., Stevenson, P. and Shaw, A. (2001). Reality v. Rhetoric – a Survey and Evaluation of Tsetse Control in East Africa. Agriculture and Human Values 18, 219233.CrossRefGoogle Scholar
Bruce, D., Nabarro, D. and Greig, E. D. W. (1903). Further report on sleeping sickness in Uganda. Reports of the Sleeping Sickness Commission of the Royal Society 4, 187.Google Scholar
Burri, C. and Brun, R. (2003). Eflornithine for treatment of human African trypanosomiasis. Parasitology Research 90 (Supp 1), S49–52.Google ScholarPubMed
Burri, C. and Keiser, J. (2001). Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment. Tropical Medicine and International Health 6, 412420.CrossRefGoogle ScholarPubMed
Chappuis, F., Udayraj, N., Stietenroth, K., Meussen, A. and Bovier, P. A. (2005). Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis. Clinical Infectious Diseases 41, 748751.CrossRefGoogle ScholarPubMed
Checchi, F., Filipe, J. A., Barrett, M. P. and Chandramohan, D. (2008 b). The natural progression of gambiense sleeping sickness: what is the evidence? PLoS Neglected Tropical Diseases 2, e303.CrossRefGoogle ScholarPubMed
Checchi, F., Filipe, J. A., Haydon, D. T., Chandramohan, D. and Chappuis, F. (2008 a). Estimates of the duration of the early and late stage of gambiense sleeping sickness. BMC Infectious Diseases 8, 16.CrossRefGoogle ScholarPubMed
Courtin, F., Jamonneau, V., Duvallet, G., Garcia, A., Coulibaly, B., Doumenge, J. P., Cuny, G. and Solano, P. (2008). Sleeping sickness in West Africa (1906–2006): changes in spatial repartition and lessons from the past. Tropical Medicine and International Health 13, 334344.CrossRefGoogle ScholarPubMed
Courtioux, B., Bisser, S., M'belesso, P., Ngoungou, E., Girard, M., Nangouma, A., Josenando, T., Jauberteau-Marchan, M. O. and Bouteille, B. (2005). Dot enzyme-linked immunosorbent assay for more reliable staging of patients with Human African Trypanosomiasis. Journal of Clinical Microbiology 43, 47894795.CrossRefGoogle ScholarPubMed
Croft, S. L. (2008). Kinetoplastida: new therapeutic strategies. Parasite 15, 522527.CrossRefGoogle ScholarPubMed
Deborggraeve, S., Claes, F., Laurent, T., Mertens, P., Leclipteux, T., Dujardin, J. C., Herdewijn, P. and Büscher, P. (2006). Molecular dipstick test for diagnosis of sleeping sickness. Journal of Clinical Microbiology 44, 28842889.CrossRefGoogle ScholarPubMed
Deborggraeve, S., Koffi, M., Jamonneau, V., Bonsu, F. A., Queyson, R., Simarro, P. P., Herdewijn, P. and Büscher, P. (2008). Molecular analysis of archived blood slides reveals an atypical human Trypanosoma infection. Diagnostic microbiology and infectious disease 61, 428433.CrossRefGoogle ScholarPubMed
Enserink, M. (2007). Entomology. Welcome to Ethiopia's fly factory. Science 317, 310313.CrossRefGoogle ScholarPubMed
Fèvre, E. M., Coleman, P. G., Odiit, M., Magona, J. W., Welburn, S. C. and Woolhouse, M. E. J. (2001). The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda. Lancet 358, 625628.CrossRefGoogle ScholarPubMed
Fèvre, E. M., Coleman, P. G., Welburn, S. C. and Maudlin, I. (2004). Reanalyzing the 1900–1920 sleeping sickness epidemic in Uganda. Emerging Infectious Diseases 10, 567573.CrossRefGoogle ScholarPubMed
Fèvre, E. M., Odiit, M., Coleman, P. G., Woolhouse, M. E. and Welburn, S. C. (2008 b). Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda. BMC Public Health 8, 96.CrossRefGoogle ScholarPubMed
Fèvre, E. M., Wissmann, B. V., Welburn, S. C. and Lutumba, P. (2008 a). The burden of human African trypanosomiasis. PLoS Neglected Tropical Disease 2, e333.CrossRefGoogle ScholarPubMed
Hargrove, J. W. (2003). Tsetse Eradication: Sufficiency, Necessity and Desirability. (Research Report, DFID Animal Health Programme). http://www0.sun.ac.za/sacema/publications/TsetseEradication.htmlGoogle Scholar
Haydon, D. T., Cleaveland, S., Taylor, L. H. and Laurenson, M. K. (2002). Identifying reservoirs of infection: a conceptual and practical challenge. Emerging Infectious Diseases 8, 14681473.Google ScholarPubMed
Heisch, R. B., McMahon, J. P. and Manson-Bahr, P. E. C. (1958). The isolation of Trypanosoma rhodesiense from a bushbuck. British Medical Journal ii, 12031204.CrossRefGoogle Scholar
Jannin, J. and Cattand, P. (2004). Treatment and control of human African trypanosomiasis. Current Opinion in Infectious Diseases 17, 565571.CrossRefGoogle ScholarPubMed
Kaba, D., Dje, N. N., Courtin, F., Oke, E., Koffi, M., Garcia, A., Jamonneau, V. and Solano, P. (2006). The impact of war on the evolution of sleeping sickness in west-central Côte d'Ivoire. Tropical Medicine and International Health 11, 136143.CrossRefGoogle ScholarPubMed
Kabasa, J. D. (2007). Public-private partnership works to stamp out sleeping sickness in Uganda. Trends in Parasitology 23, 191192.CrossRefGoogle ScholarPubMed
Kennedy, P. G. (2006). Diagnostic and neuropathogenesis issues in human African trypanosomiasis. International Journal for Parasitology 36, 505512.CrossRefGoogle ScholarPubMed
Kgori, P. M., Modo, S. and Torr, S. J. (2006). The use of aerial spraying to eliminate tsetse from the Okavango Delta of Botswana. Acta Tropica 99, 184199.CrossRefGoogle ScholarPubMed
King, C. H. and Bertino, A. M. (2008). Asymmetries of poverty: Why global burden of disease valuations underestimate the burden of neglected tropical diseases. PLoS Neglected Tropical Diseases 2, e209.CrossRefGoogle ScholarPubMed
Lancien, J. (1991). Campaign against sleeping sickness in South-West Uganda by trapping tsetse flies. Annales de la Société belge de médecine tropicale. 71 (Suppl 1), 3547.Google ScholarPubMed
Lejon, V., Jamonneau, V., Solano, P., Atchade, P., Mumba, D., Nkoy, N., Bébronne, N., Kibonja, T., Balharbi, F., Wierckx, A., Boelaert, M. and Büscher, P. (2006). Detection of trypanosome-specific antibodies in saliva, towards non-invasive serological diagnosis of sleeping sickness. Tropical Medicine and International Health 11, 620627.CrossRefGoogle ScholarPubMed
Lejon, V., Legros, D., Richer, M., Ruiz, J. A., Jamonneau, V., Truc, P., Doua, F., Djé, N., N'Siesi, F. X., Bisser, S., Magnus, E., Wouters, I., Konings, J., Vervoort, T., Sultan, F. and Büscher, P. (2002). IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test. Tropical Medicine and International Health 7, 685692.CrossRefGoogle ScholarPubMed
Lutumba, P., Robays, J., Miaka, C., Kande, V., Mumba, D., Büscher, P., Dujardin, B. and Boelaert, M. (2006). Validity, cost and feasibility of the mAECT and CTC confirmation tests after diagnosis of African of sleeping sickness. Tropical Medicine and International Health 11, 470478.CrossRefGoogle ScholarPubMed
Lutumba, P., Makieya, E., Shaw, A., Meheus, F. and Boelaert, M. (2007). Human African trypanosomiasis in a rural community, Democratic Republic of Congo. Emerging Infectious Diseases 13, 248254.CrossRefGoogle Scholar
Lyons, M. (1992). The Colonial Disease. A Social History of Sleeping Sickness in Northern Zaire, 1900–1940. Cambridge, UK: Cambridge University Press.CrossRefGoogle Scholar
Maudlin, I. (2006). African trypanosomiasis. Annnals of Tropical Medicine and Parasitology 100, 679701.CrossRefGoogle ScholarPubMed
Milinski, M., Semmann, D. and Krambeck, H. J. (2002). Reputation helps solve the ‘tragedy of the commons’. Nature 415, 424426.CrossRefGoogle ScholarPubMed
Molyneux, D. H. (2008). Combating the “other diseases” of MDG 6: changing the paradigm to achieve equity and poverty reduction? Transactions of the Royal Society of Tropical Medicine and Hygiene 102, 509519.CrossRefGoogle ScholarPubMed
Molyneux, D. H., Hopkins, D. R. and Zagaria, N. (2004). Disease eradication, elimination and control: the need for accurate and consistent usage. Trends in Parasitology 20, 347351.CrossRefGoogle ScholarPubMed
Molyneux, D. H., Hotez, P. J. and Fenwick, A. (2005). “Rapid-impact interventions”: How a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Medicine 2, e336.CrossRefGoogle Scholar
Njiokou, F., Laveissiere, C., Simo, G., Nkinin, S., Grébaut, P., Cuny, G. and Herder, S. (2006). Wild fauna as a probable animal reservoir for Trypanosoma brucei gambiense in Cameroon. Infection, Genetics and Evolution 6, 147153.CrossRefGoogle ScholarPubMed
Njiru, Z. K., Mikosza, A. S., Matovu, E., Enyaru, J. C., Ouma, J. O., Kibona, S. N., Thompson, R. C. and Ndung'u, J. M. (2008). African trypanosomiasis: Sensitive and rapid detection of the sub-genus Trypanozoon by loop-mediated isothermal amplification (LAMP) of parasite DNA. International Journal for Parasitology 38, 589599.CrossRefGoogle ScholarPubMed
Odiit, M., Coleman, P. G., Liu, W. C., McDermott, J. J., Fèvre, E. M., Welburn, S. C. and Woolhouse, M. E. (2005). Quantifying the level of under-detection of Trypanosoma brucei rhodesiense sleeping sickness cases. Tropical Medicine and International Health 10, 840849.CrossRefGoogle ScholarPubMed
Odiit, M., Kansiime, F. and Enyaru, J. C. K. (1997). Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda. East African Medical Journal 74, 792795.Google ScholarPubMed
Okoth, J. O. (1999). Tsetse and trypanosomiasis control problems in south-east Uganda: past, present and alternative strategies. Schweizerische medizinische Wochenschrift 129, 10911098.Google ScholarPubMed
Okoth, J. O., Okethi, V. and Ogola, A. (1991). Control of tsetse and trypanosomiasis transmission in Uganda by applications of lambda-cyhalothrin. Medical and Veterinary Entomology 5, 121128.CrossRefGoogle ScholarPubMed
Onyango, R. J., van Hoeve, K. and de Raadt, P. (1966). The epidemiology of Trypanosoma rhodesiense sleeping sickness in Alego location, central Nyanza, Kenya. I. Evidence that cattle may act as reservoir hosts of trypanosomes infective to man. Transactions of the Royal Society of Tropical Medicine and Hygiene 60, 175182.CrossRefGoogle Scholar
Papadopoulos, M. C., Abel, P. M., Agranoff, D., Stich, A., Tarelli, E., Bell, B. A., Planche, T., Loosemore, A., Saadoun, S., Wilkins, P. and Krishna, S. (2004). A novel and accurate diagnostic test for human African trypanosomiasis. Lancet 363, 13581363.CrossRefGoogle ScholarPubMed
Picozzi, K., Fèvre, E. M., Odiit, M., Carrington, M., Eisler, M. C., Maudlin, I. and Welburn, S. C. (2005). Sleeping sickness in Uganda: a thin line between two fatal diseases. British Medical Journal 331, 12381244.CrossRefGoogle ScholarPubMed
Priotto, G., Fogg, C., Balasegaram, M., Erphas, O., Louga, A., Checchi, F., Ghabri, S. and Piola, P. (2006). Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: A randomized clinical trial in Uganda. PLoS Clinical Trials 1, e39, 18.CrossRefGoogle ScholarPubMed
Priotto, G., Kasparian, S., Ngouama, D., Ghorashian, S., Arnold, U., Ghabri, S. and Karunakara, U. (2007). Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo. Clinical Infectious Diseases 45, 14351442.CrossRefGoogle ScholarPubMed
Priotto, G., Pinoges, L., Fursa, I. B., Burke, B., Nicolay, N., Grillet, G., Hewison, C. and Balasegaram, M. (2008). Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study. British Medical Journal 336, 705708.CrossRefGoogle ScholarPubMed
Robays, J., Nyamowala, G., Sese, C., Betu Ku Mesu Kande, V., Lutumba, P., Van der Veken, W. and Boelaert, M. (2008). High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo. Emerging Infectious Diseases 14, 966967.CrossRefGoogle ScholarPubMed
Simarro, P. P., Jannin, J. and Cattand, P. (2008). Eliminating human African trypanosomiasis: where do we stand and what comes next? PLoS Medicine 5, e55.CrossRefGoogle ScholarPubMed
Simarro, P. P., Ruiz, J. A., Franco, J. R. and Josenando, T. (1999). Attitude towards CATT-positive individuals without parasitological confirmation in the African Trypanosomiasis (T.b.gambiense) focus of Quicama (Angola). Tropical Medicine and International Health 4, 858861.CrossRefGoogle Scholar
Simo, G., Asonganyi, T., Nkinin, S. W., Njiokou, F. and Herder, S. (2006). High prevalence of Trypanosoma brucei gambiense group 1 in pigs from the Fontem sleeping sickness focus in Cameroon. Veterinary Parasitology 139, 5766.CrossRefGoogle ScholarPubMed
Stanghellini, A. and Josenando, T. (2001). The situation of sleeping sickness in Angola: a calamity. Tropical Medicine and International Health 6, 330334.CrossRefGoogle ScholarPubMed
Thompson, J. W., Mitchell, M., Rees, R. B., Shereni, W., Scoenfield, A. H. and Wilson, A. (1991). Studies on the efficacy of deltamethrin applied to cattle for the control of tsetse flies (Glossina spp.) in southern Africa. Tropical Animal Health and Production 23, 221226.CrossRefGoogle Scholar
Torr, S. J., Maudlin, I. and Vale, G. A. (2007). Less is more: restricted application of insecticide to cattle to improve the cost and efficacy of tsetse control. Medical and Veterinary Entomology 21, 5364.CrossRefGoogle ScholarPubMed
Vreysen, M. J., Saleh, K. M., Ali, M. Y., Abdulla, A. M., Zhu, Z. R., Juma, K. G., Dyck, V. A., Msangi, A. R., Mkonyi, P. A. and Feldmann, H. U. (2000). Glossina austeni (Diptera: Glossinidae) eradicated on the island of Unguja, Zanzibar, using the sterile insect technique. Journal of Economic Entomology 93, 123135.CrossRefGoogle ScholarPubMed
Welburn, S. C., Coleman, P. G., Maudlin, I., Fèvre, E. M., Odiit, M. and Eisler, M. C. (2006). Crisis, what crisis? Control of Rhodesian sleeping sickness. Trends in Parasitology 22, 123128.CrossRefGoogle ScholarPubMed
Welburn, S. C., Fèvre, E. M., Coleman, P. G., Odiit, M. and Maudlin, I. (2001 b). Sleeping sickness: a tale of two diseases. Trends in Parasitology 17, 1924.CrossRefGoogle ScholarPubMed
Welburn, S. C., Picozzi, K., Fèvre, E. M., Coleman, P. G., Odiit, M., Carrington, M. and Maudlin, I. (2001 a). Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene. Lancet 358, 20172019.CrossRefGoogle ScholarPubMed
WHO (1998). Control and Surveillance of African Trypanosomiasis. Geneva, WHO.Google Scholar
World Bank Group (2006). World Development Indicators. World Bank Group Edition: 10, revised. World Bank Publications, 385 pages.Google Scholar
69
Cited by

Save article to Kindle

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Controlling sleeping sickness – a review
Available formats
×

Save article to Dropbox

To save this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about saving content to Dropbox.

Controlling sleeping sickness – a review
Available formats
×

Save article to Google Drive

To save this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about saving content to Google Drive.

Controlling sleeping sickness – a review
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *